116 related articles for article (PubMed ID: 38224097)
21. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
[TBL] [Abstract][Full Text] [Related]
22. Circulating Lamin B1 (LMNB1) biomarker detects early stages of liver cancer in patients.
Sun S; Xu MZ; Poon RT; Day PJ; Luk JM
J Proteome Res; 2010 Jan; 9(1):70-8. PubMed ID: 19522540
[TBL] [Abstract][Full Text] [Related]
23. Identifying
Xiang X; Gao LM; Zhang Y; Zhu Q; Zhao S; Liu W; Ye Y; Tang Y; Zhang W
PeerJ; 2023; 11():e16618. PubMed ID: 38099311
[TBL] [Abstract][Full Text] [Related]
24. De Novo Variants in LMNB1 Cause Pronounced Syndromic Microcephaly and Disruption of Nuclear Envelope Integrity.
Cristofoli F; Moss T; Moore HW; Devriendt K; Flanagan-Steet H; May M; Jones J; Roelens F; Fons C; Fernandez A; Martorell L; Selicorni A; Maitz S; Vitiello G; Van der Hoeven G; Skinner SA; Bollen M; Vermeesch JR; Steet R; Van Esch H
Am J Hum Genet; 2020 Oct; 107(4):753-762. PubMed ID: 32910914
[TBL] [Abstract][Full Text] [Related]
25. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B
Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843
[TBL] [Abstract][Full Text] [Related]
26. Reduced expression of ferroportin1 and ceruloplasmin predicts poor prognosis in adrenocortical carcinoma.
Zhu B; Zhi Q; Xie Q; Wu X; Gao Y; Chen X; Shi L
J Trace Elem Med Biol; 2019 Dec; 56():52-59. PubMed ID: 31442954
[TBL] [Abstract][Full Text] [Related]
27. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F
Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409
[TBL] [Abstract][Full Text] [Related]
28. A novel family with Lamin B1 duplication associated with adult-onset leucoencephalopathy.
Brussino A; Vaula G; Cagnoli C; Mauro A; Pradotto L; Daniele D; Di Gregorio E; Barberis M; Arduino C; Squadrone S; Abete MC; Migone N; Calabrese O; Brusco A
J Neurol Neurosurg Psychiatry; 2009 Feb; 80(2):237-40. PubMed ID: 19151023
[TBL] [Abstract][Full Text] [Related]
29. IL-13Rα2 gene expression is a biomarker of adverse outcome in patients with adrenocortical carcinoma.
Kumar A; Bellayr IH; Singh HS; Puri RK
PLoS One; 2021; 16(2):e0246632. PubMed ID: 33591997
[TBL] [Abstract][Full Text] [Related]
30. Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours.
Dos Santos Passaia B; Lima K; Kremer JL; da Conceição BB; de Paula Mariani BM; da Silva JCL; Zerbini MCN; Fragoso MCBV; Machado-Neto JA; Lotfi CFP
Invest New Drugs; 2020 Jun; 38(3):899-908. PubMed ID: 31441020
[TBL] [Abstract][Full Text] [Related]
31. Construction of a robust prognostic model for adult adrenocortical carcinoma: Results from bioinformatics and real-world data.
Tian X; Xu WH; Anwaier A; Wang HK; Wan FN; Cao DL; Luo WJ; Shi GH; Qu YY; Zhang HL; Ye DW
J Cell Mol Med; 2021 Apr; 25(8):3898-3911. PubMed ID: 33626208
[TBL] [Abstract][Full Text] [Related]
32. Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma.
Fu Y; Sun S; Bi J; Kong C; Yin L
Medicine (Baltimore); 2021 Mar; 100(10):e25031. PubMed ID: 33725886
[TBL] [Abstract][Full Text] [Related]
33. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of LMNB1 Inhibits the Proliferation of Lung Adenocarcinoma Cells by Inducing DNA Damage and Cell Senescence.
Li J; Sun Z; Cui Y; Qin L; Wu F; Li Y; Du N; Li X
Front Oncol; 2022; 12():913740. PubMed ID: 35712471
[TBL] [Abstract][Full Text] [Related]
35. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune-related pathways.
Veronez LC; das Chagas PF; Corrêa CAP; Baroni M; da Silva KR; Nagano LF; Borges KS; Queiroz RGP; Tone LG; Scrideli CA
J Cell Biochem; 2021 Dec; 122(12):1925-1935. PubMed ID: 34581457
[TBL] [Abstract][Full Text] [Related]
36. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
Shen C; Liu J; Yang X; Jiao W; Wang Y
Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
[TBL] [Abstract][Full Text] [Related]
37. A family with autosomal dominant leukodystrophy linked to 5q23.2-q23.3 without lamin B1 mutations.
Brussino A; Vaula G; Cagnoli C; Panza E; Seri M; Di Gregorio E; Scappaticci S; Camanini S; Daniele D; Bradac GB; Pinessi L; Cavalieri S; Grosso E; Migone N; Brusco A
Eur J Neurol; 2010 Apr; 17(4):541-9. PubMed ID: 19961535
[TBL] [Abstract][Full Text] [Related]
38. An absence of both lamin B1 and lamin B2 in keratinocytes has no effect on cell proliferation or the development of skin and hair.
Yang SH; Chang SY; Yin L; Tu Y; Hu Y; Yoshinaga Y; de Jong PJ; Fong LG; Young SG
Hum Mol Genet; 2011 Sep; 20(18):3537-44. PubMed ID: 21659336
[TBL] [Abstract][Full Text] [Related]
39. Redistribution of the Lamin B1 genomic binding profile affects rearrangement of heterochromatic domains and SAHF formation during senescence.
Sadaie M; Salama R; Carroll T; Tomimatsu K; Chandra T; Young AR; Narita M; Pérez-Mancera PA; Bennett DC; Chong H; Kimura H; Narita M
Genes Dev; 2013 Aug; 27(16):1800-8. PubMed ID: 23964094
[TBL] [Abstract][Full Text] [Related]
40. Identification of important invasion and proliferation related genes in adrenocortical carcinoma.
Alshabi AM; Vastrad B; Shaikh IA; Vastrad C
Med Oncol; 2019 Jul; 36(9):73. PubMed ID: 31321566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
